Business Wire

TRIPLE-1/FUJITSU

18.3.2019 16:02:06 CET | Business Wire | Press release

Share
TRIPLE-1, Inc. Signed a Distributorship Contract with Fujitsu Electronics Inc.

TRIPLE-1, Inc. (Representative Director: Takuya Yamaguchi) and Fujitsu Electronics Inc. (Representative Director: Junji Ogihara) have entered into a distributorship contract for a mining ASIC (application specific IC) “KAMIKAZE” that uses the world's most advanced 7nm process technology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190318005034/en/

--- Background:

In the development market for mining ICs, which requires huge computing power and high power efficiency, the introduction of advanced process technology has been attempted positively and just like the development market for ICs for smartphones, which is one of the world's leading manufacture industries, the driving force for development came from the process miniaturization in the advanced semiconductor industry. As of 2019, there is a mover away from the mainstream 16nm process which had been the oligopoly of traditional Chinese region manufacturers to the state-of-the-art 7nm process. In the past, several companies, including Japanese companies, announced their entry into cutting-edge 7nm process development, but at the moment there are only a handful of manufacturers that have succeeded in commercializing ASIC (application specific IC).

--- Purpose / Perspective:

TRIPLE-1 is a semiconductor system development company established in November 2016 and specializing in cutting-edge process technology.
Since February 2017, we began to develop the ASIC (application specific IC) "KAMIKAZE" for bitcoin mining adopting the world's most advanced 7nm process technology.
About a year later in February 2018, we announced the world's first tape-out (design completion) in the state-of-the-art 7nm process for the same application and proceeded with commercialization by TSMC (Taiwan), the world's largest foundry.
Currently TRIPLE-1 is the only manufacturer of ASIC (application specific IC) that adopts the state-of-the-art 7nm process technology in Japan and is the only Japanese company that confronts the world in the cutting-edge process development market.
Fujitsu Electronics develops a wide range of products from various brands and manufacturers for markets around the world by making full use of the global network spreading both in Japan and abroad, centered on the "Fujitsu brand" that has continued to be trusted for many years around the world.
Through the signing of this distributorship contract, we will be able to spread the global development potential of Fujitsu Electronics and the state-of-the-art process development capabilities of TRIPLE-1 all over the world and provide the real value of “Japanese manufacturing” to markets around the world. On top of that, by establishing a long-term and strong partnership, we will cooperate not only in mining ASIC (application specific IC), but also in the development and deployment of leading-edge products for various fields and applications.

--- TRIPLE-1 “KAMIKAZE” Product Features:

1. Adopts the world's most advanced 7nm process technology
Develops the world's first "KAMIKAZE", an ASIC (application specific IC) for bitcoin mining with using world's Leading-Edge company TSMC (Taiwan) ’s 7nm process technology and evaluates the first tape out (first generation) version, Power Efficiency: 52 J / TH was realized (measured on September 26, 2018).

2. Reduced energy consumption that contributes to energy resource conservation
By operating at ultra-low voltage (0.3V or less) and achieving low power consumption, it is possible to contribute to the reduction of the enormous power required for mining and energy resource conservation while maintaining a high performance.

3. High cooling efficiency from changes in packaging
In order to achieve higher cooling efficiency, we adopted a structure (exposed die - FCBGA) in which the backside of the silicon chip is exposed on the package to achieve higher cooling efficiency, chip size was encapsulated in 7 mm × 7 mm.

--- TRIPLE-1 outline:

Company Name: TRIPLE-1, Inc.
Corporate Headquarter:
7F IT Bldg.Ⅱ,1-14-20 Hakataeki-Higashi, Hakata-ku Fukuoka-shi, Fukuoka, Japan
Representatives: Representative Director CEO Takuya Yamaguchi
The capital: 3662 million 895 thousand and 398 yen (including the capital reserve)

--- Features of Fujitsu Electronics:

As an "Electronics General Trading Company" that contributes to the development of customers' businesses through offering an extensive lineup of Fujitsu brand products centered on LSIs with leading-edge technology and proprietary products, as well as domestic and overseas manufacturer products, with comprehensive support including sales, technology, solution services, logistic services and more. With 13 locations in Japan and 20 locations overseas, we have established a global distributor system that can propose a wide range of solutions, building a consistent network that can respond to customer requests in a timely manner, from product procurement to development and mass production.

--- Fujitsu Electronics outline:

Company Name: Fujitsu Electronics Inc.
Corporate Headquarter:
2-100-45, Shin-Yokohama, Kohoku-Ku, Yokohama-shi, Kanagawa, Japan
Representatives: President and Representative Director Junji Ogihara
The capital: 4,877,683,581 yen
Website: http://www.fujitsu.com/jp/fei/en/

--- About the trademark:

Proper nouns such as the product names listed are trademarks or registered trademarks of their respective owners.

Contact:

Regarding this Press Release: TRIPLE-1, Inc. Public Relations Office GAKU MATSUSHIMA info@triple-1.com

Regarding Sales and Products: Fujitsu Electronics Inc. fei-triple1@dl.jp.fujitsu.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release

Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh

Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release

- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur

Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye